Metabolic stress regulates cytoskeletal dynamics and metastasis of cancer cells.

Metabolic reprogramming is an important driver of tumor progression; however, the metabolic regulators of tumor cell motility and metastasis are not understood. Here, we show that tumors maintain energy production under nutrient deprivation through the function of HSP90 chaperones compartmentalized in mitochondria. Using cancer cell lines, we found that mitochondrial HSP90 proteins, including tumor necrosis factor receptor-associated protein-1 (TRAP-1), dampen the activation of the nutrient-sensing AMPK and its substrate UNC-51-like kinase (ULK1), preserve cytoskeletal dynamics, and release the cell motility effector focal adhesion kinase (FAK) from inhibition by the autophagy initiator FIP200. In turn, this results in enhanced tumor cell invasion in low nutrients and metastatic dissemination to bone or liver in disease models in mice. Moreover, we found that phosphorylated ULK1 levels were correlated with shortened overall survival in patients with non-small cell lung cancer. These results demonstrate that mitochondrial HSP90 chaperones, including TRAP-1, overcome metabolic stress and promote tumor cell metastasis by limiting the activation of the nutrient sensor AMPK and preventing autophagy.

[1]  D. St Johnston,et al.  LKB1 and AMPK maintain epithelial cell polarity under energetic stress , 2013, The Journal of cell biology.

[2]  M. Herlyn,et al.  Control of tumor bioenergetics and survival stress signaling by mitochondrial HSP90s. , 2012, Cancer cell.

[3]  Navdeep S. Chandel,et al.  AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress , 2012, Nature.

[4]  E. White.  Deconvoluting the context-dependent role for autophagy in cancer , 2012, Nature Reviews Cancer.

[5]  K. Wellen,et al.  A two-way street: reciprocal regulation of metabolism and signalling , 2012, Nature Reviews Molecular Cell Biology.

[6]  S. Berger,et al.  IDH mutation impairs histone demethylation and results in a block to cell differentiation , 2012, Nature.

[7]  R. Verhaak,et al.  Transformation by the R Enantiomer of 2-Hydroxyglutarate Linked to EglN Activation , 2012, Nature.

[8]  S. Lowe,et al.  The microcosmos of cancer , 2012, Nature.

[9]  Stephanie Alexander,et al.  Cancer Invasion and the Microenvironment: Plasticity and Reciprocity , 2011, Cell.

[10]  L. Platanias,et al.  Emerging roles for mammalian target of rapamycin inhibitors in the treatment of solid tumors and hematological malignancies , 2011, Current opinion in oncology.

[11]  S. Wesselborg,et al.  Role of AMPK-mTOR-Ulk1/2 in the Regulation of Autophagy: Cross Talk, Shortcuts, and Feedbacks , 2011, Molecular and Cellular Biology.

[12]  Robert A. Weinberg,et al.  Tumor Metastasis: Molecular Insights and Evolving Paradigms , 2011, Cell.

[13]  A. Kimmelman,et al.  The dynamic nature of autophagy in cancer. , 2011, Genes & development.

[14]  Yun Zhang,et al.  The chemokine receptor CX3CR1 is directly involved in the arrest of breast cancer cells to the skeleton , 2011, Breast Cancer Research.

[15]  R. Shaw,et al.  The AMPK signalling pathway coordinates cell growth, autophagy and metabolism , 2011, Nature Cell Biology.

[16]  J. Cleveland,et al.  Hsp90-Cdc37 chaperone complex regulates Ulk1- and Atg13-mediated mitophagy. , 2011, Molecular cell.

[17]  C. Dang,et al.  Otto Warburg's contributions to current concepts of cancer metabolism , 2011, Nature Reviews Cancer.

[18]  J. Guan,et al.  Suppression of autophagy by FIP200 deletion inhibits mammary tumorigenesis. , 2011, Genes & development.

[19]  Gerald C. Chu,et al.  Proinvasion metastasis drivers in early-stage melanoma are oncogenes. , 2011, Cancer cell.

[20]  M. Peppelenbosch,et al.  The long and winding road to rational treatment of cancer associated with LKB1/AMPK/TSC/mTORC1 signaling , 2011, Oncogene.

[21]  J. D. De Mey,et al.  FAK phosphorylation at Tyr-925 regulates cross-talk between focal adhesion turnover and cell protrusion , 2011, Molecular biology of the cell.

[22]  A. Ross,et al.  Exploiting the mitochondrial unfolded protein response for cancer therapy in mice and human cells. , 2011, The Journal of clinical investigation.

[23]  B. Viollet,et al.  AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1 , 2011, Nature Cell Biology.

[24]  B. Viollet,et al.  Phosphorylation of ULK1 (hATG1) by AMP-Activated Protein Kinase Connects Energy Sensing to Mitophagy , 2011, Science.

[25]  M. Eck,et al.  The FERM domain: organizing the structure and function of FAK , 2010, Nature Reviews Molecular Cell Biology.

[26]  S. Kornbluth,et al.  The engine driving the ship: metabolic steering of cell proliferation and death , 2010, Nature Reviews Molecular Cell Biology.

[27]  S. Lindquist,et al.  HSP90 at the hub of protein homeostasis: emerging mechanistic insights , 2010, Nature Reviews Molecular Cell Biology.

[28]  S. Gygi,et al.  Network organization of the human autophagy system , 2010, Nature.

[29]  Michael D Schaller,et al.  Cellular functions of FAK kinases: insight into molecular mechanisms and novel functions , 2010, Journal of Cell Science.

[30]  L. Languino,et al.  IAP regulation of metastasis. , 2010, Cancer cell.

[31]  L. Liau,et al.  Cancer-associated IDH1 mutations produce 2-hydroxyglutarate , 2009, Nature.

[32]  Hanna Y. Irie,et al.  Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment , 2009, Nature.

[33]  L. Cantley,et al.  Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.

[34]  W. Gerald,et al.  Genes that mediate breast cancer metastasis to the brain , 2009, Nature.

[35]  Kun-Liang Guan,et al.  Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1α , 2009, Science.

[36]  C. Jung,et al.  ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery. , 2009, Molecular biology of the cell.

[37]  L. Neckers,et al.  Combinatorial drug design targeting multiple cancer signaling networks controlled by mitochondrial Hsp90. , 2009, The Journal of clinical investigation.

[38]  N. Dolloff,et al.  The α-receptor for platelet-derived growth factor as a target for antibody-mediated inhibition of skeletal metastases from prostate cancer cells , 2009, Oncogene.

[39]  Brian Keith,et al.  HIF-alpha effects on c-Myc distinguish two subtypes of sporadic VHL-deficient clear cell renal carcinoma. , 2008, Cancer cell.

[40]  Guido Kroemer,et al.  Tumor cell metabolism: cancer's Achilles' heel. , 2008, Cancer cell.

[41]  J. Guan,et al.  FIP200, a ULK-interacting protein, is required for autophagosome formation in mammalian cells , 2008, The Journal of cell biology.

[42]  D. Altieri,et al.  Regulation of Tumor Cell Mitochondrial Homeostasis by an Organelle-Specific Hsp90 Chaperone Network , 2007, Cell.

[43]  D. Neil Hayes,et al.  LKB1 modulates lung cancer differentiation and metastasis , 2007, Nature.

[44]  Jun Hee Lee,et al.  Energy-dependent regulation of cell structure by AMP-activated protein kinase , 2007, Nature.

[45]  B. Viollet,et al.  5′-AMP-Activated Protein Kinase (AMPK) Is Induced by Low-Oxygen and Glucose Deprivation Conditions Found in Solid-Tumor Microenvironments , 2006, Molecular and Cellular Biology.

[46]  Anupama E. Gururaj,et al.  p21-activated kinases in cancer , 2006, Nature Reviews Cancer.

[47]  M. Hall,et al.  TOR Signaling in Growth and Metabolism , 2006, Cell.

[48]  D. Green,et al.  The Pathophysiology of Mitochondrial Cell Death , 2004, Science.

[49]  Daniel St Johnston,et al.  A role for Drosophila LKB1 in anterior–posterior axis formation and epithelial polarity , 2003, Nature.

[50]  Hiroki Ueda,et al.  Regulation of focal adhesion kinase by a novel protein inhibitor FIP200. , 2002, Molecular biology of the cell.

[51]  D. Sabatini,et al.  mTOR Interacts with Raptor to Form a Nutrient-Sensitive Complex that Signals to the Cell Growth Machinery , 2002, Cell.

[52]  Junying Yuan,et al.  LKB1 — A master tumour suppressor of the small intestine and beyond , 2002, Nature Reviews Cancer.

[53]  Richard A. Szucs,et al.  TNM Classification of Malignant Tumors. 5th ed , 1998 .

[54]  A. Hall,et al.  Cell migration: Rho GTPases lead the way. , 2004, Developmental biology.